Related Experiment Video
Updated: Jul 5, 2026
06:19
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
Triptolide modulates T-cell inflammatory responses and ameliorates experimental autoimmune encephalomyelitis
Ying Wang1, Yunhua Mei, Dechun Feng
1Shanghai Institute of Immunology, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Journal of Neuroscience Research
|April 29, 2008
Summary
Triptolide (TPT) shows protective effects against experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis. TPT treatment reduced disease severity, inflammation, and demyelination by modulating immune responses.
Area of Science:
- Immunology
- Neuroscience
- Pharmacology
Background:
- Triptolide (TPT) is a diterpenoid triepoxide from Tripterygium wilfordii Hook. f.
- TPT exhibits immunosuppressive properties, aiding graft survival and autoimmune response suppression.
Purpose of the Study:
- To investigate the protective potential of TPT in experimental autoimmune encephalomyelitis (EAE).
- To evaluate TPT's effects on immune responses in a multiple sclerosis animal model.
Main Methods:
- C57BL/6 mice were induced with EAE and treated with TPT.
- Analysis included disease severity scoring, histological examination of central nervous system tissues, cytokine mRNA expression, Forkhead box p3 (Foxp3) expression, and nuclear factor-kappa B (NF-kappaB) pathway activity.
Main Results:
- TPT treatment significantly delayed EAE onset and reduced disease severity.
- Reduced inflammation and demyelination were observed in the central nervous system.
- TPT inhibited Th1/Th17 and Th2 cytokine expression, upregulated Foxp3, and modulated NF-kappaB signaling.
Conclusions:
- TPT demonstrates significant immunoregulatory functions.
- TPT holds potential therapeutic value for autoimmune inflammatory disorders like multiple sclerosis.
Related Concept Videos
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...